Stock listing
CTMX Stock Price, News, Filings & Events — Cytomx Therapeutics, Inc.
Selected listing: CTMX · NASDAQ · USD · US
This page tracks Cytomx Therapeutics, Inc.'s CTMX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CTMX:NASDAQ. CTMX:NASDAQ is the stock-level entry point for investors researching Cytomx Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cytomx Therapeutics, Inc. is a public biotechnology company based in the United States, trading under the ticker CTMX. The company focuses on developing innovative cancer therapies using its proprietary Probody platform. As of now, Cytomx has a market capitalization of approximately $788 million.
- Ticker
- CTMX:NASDAQ
- Asset type
- Stock
- Market cap
- $699.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Cytomx Therapeutics, Inc. CTMX:NASDAQ stock context
This page tracks Cytomx Therapeutics, Inc.'s CTMX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CTMX:NASDAQ. CTMX:NASDAQ is the stock-level entry point for investors researching Cytomx Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cytomx Therapeutics, Inc. is a public biotechnology company based in the United States, trading under the ticker CTMX. The company focuses on developing innovative cancer therapies using its proprietary Probody platform. As of now, Cytomx has a market capitalization of approximately $788 million.
Latest news from Cytomx Therapeutics, Inc.
CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan (“Varseta-M”) for Relapsed/Refractory Metastatic Colore...
August 27, 2026
CytomX Therapeutics Appoints Alejandra Carvajal as Chief Legal Officer
August 3, 2026
CytomX Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026
July 30, 2026
CytomX Therapeutics Announces Appointment of Charles Fuchs, M.D., M.P.H., to the Board of Directors
July 27, 2026
CytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the...
June 3, 2026
Cytomx Therapeutics, Inc. earnings calls
CytomX Therapeutics, Inc. (CTMX) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
CytomX Therapeutics, Inc. (CTMX) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
CytomX Therapeutics, Inc. (CTMX) Q4 2025 Earnings Call
March 16, 2026 · Replay with transcript and chapters
CytomX Therapeutics, Inc. (CTMX) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
CytomX Therapeutics, Inc. (CTMX) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
CytomX Therapeutics, Inc. (CTMX) Q1 2025 Earnings Call
May 12, 2025 · Replay with transcript and chapters
Research Cytomx Therapeutics, Inc.
Cytomx Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for CTMX:NASDAQ.
Cytomx Therapeutics, Inc. company profile
View the public company page for Cytomx Therapeutics, Inc. on 6ix.
Cytomx Therapeutics, Inc. news
Read company news and market updates connected to Cytomx Therapeutics, Inc..
Cytomx Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Cytomx Therapeutics, Inc..
Alternate listings
6C1:GETTEX
DE · EUR
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is CTMX:NASDAQ.
A14158:LSX
DE · EUR
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is CTMX:NASDAQ.
A14158:LS
DE · EUR
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is CTMX:NASDAQ.
6C1:TRADEGATE
DE · EUR
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is CTMX:NASDAQ.
6C1:FWB
DE · EUR
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is CTMX:NASDAQ.
CTMX:BOATS
US · USD
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is CTMX:NASDAQ.
6C1:BX
CH · CHF
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is CTMX:NASDAQ.
6C1:DUS
DE · EUR
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is CTMX:NASDAQ.
6C1:SWB
DE · EUR
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is CTMX:NASDAQ.